ArticleGlobalization and health2023
Challenges in international health financing and implications for the new pandemic fund.
Article in Globalization and health, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
23 citing papers in PubMed, 1 synthesis or guideline pooled it, 40 citations in OpenAlex.
- Civil society and perilous medicine in Africa: a systematic review.BMJ global health · 2025Pooled it
- Financing of Human Papillomavirus Vaccination in Africa: A Scoping Review.Health science reports · 2026Review
- Implementing innovative financing mechanisms in global health - perspectives of stakeholders from global health organisations: a qualitative study.Journal of global health · 2026Article
- Machine Learning Analysis of Maternal Mortality Determinants in Nigeria: An Exploratory Study.The International journal of health planning and management · 2026Article
- Japan's global health engagement in the Western Pacific: diagnosing structural inertia and a framework for human security diplomacy.The Lancet regional health. Western Pacific · 2026Review
- Not Every Country Can Absorb a Shock: Unequal Capacity to Withstand World Health Organization Aid Cuts.Public health challenges · 2026Article
- Prolonged multisectoral aid-driven reliance on health systems and governance post-conflict era in Somalia.Tropical medicine and health · 2026Review
- Governing antibiotic resistance through One Health: Insights from the political and legal landscape in Senegal.PLOS global public health · 2026Article
- Financing fragility and pandemic preparedness in Central Asia: a policy review of aid volatility, donor dynamics, and health system resilience.Frontiers in public health · 2026Article
- Strengthening pandemic prevention, preparedness, and response in Somalia: strategic implications of health security financing.Frontiers in public health · 2026Article
- Discursive structures of global development governance: a mixed-methods network analysis of an academic deliberative space in the context of FfD4.Frontiers in sociology · 2026Article
- Enhancing the role of innovative financing in global health.Global health research and policy · 2025Article
- Who funds the WHO Foundation? A transparency analysis of donation disclosures over the first 3 years of its operation.BMJ global health · 2025Article
- Obstacles to multisectoral maternal and child healthcare financing in Uganda: insights from policy bureaucrats.BMC health services research · 2025Article
- The devil's in the detail: an appraisal of the use of innovative financing mechanisms for pandemic prevention, preparedness and response.Globalization and health · 2025Article
- Global strategies for implementing health financing equity - a state-of-the-art review of political declarations.International journal for equity in health · 2025Review
- Prioritizing countries for TB vaccine readiness research using a global stakeholder-centric approach.PLOS global public health · 2025Article
- Collaborative governance of an integrated system for collecting contributions for social health insurance, pension, and taxes from the informal sector: a synthesis of stakeholder perspectives.BMC health services research · 2024Article
- Financing pandemic prevention, preparedness and response: lessons learned and perspectives for future.Globalization and health · 2024Review
- How feasible is it to mobilize $31 billion a year for pandemic preparedness and response? An economic growth modelling analysis.Globalization and health · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors at 2 institutions in 2 countries.
Funding
Abstract
backgroundThe failures of the international COVID-19 response highlighted key gaps in pandemic preparedness and response (PPR). The G20 and WHO have called for additional funding of $10.5 billion per year to adequately strengthen the global PPR architecture. In response to these calls, in 2022 the World Bank announced the launch of a new Financial Intermediary Fund (The Pandemic Fund) to catalyse this additional funding. However, there is considerable unclarity regarding the governance makeup and financial modalities of the Pandemic Fund, and divergence of opinion about whether the Fund has been successfully designed to respond to key challenges in global health financing. METHODS/
resultsThe article outlines eight challenges associated with global health financing instruments and development aid for health within the global health literature. These include misaligned aid allocation; accountability; multistakeholder representation and participation; country ownership; donor coherency and fragmentation; transparency; power dynamics, and; anti-corruption. Using available information about the Pandemic Fund, the article positions the Pandemic Fund against these challenges to determine in what ways the financing instrument recognizes, addresses, partially addresses, or ignores them. The assessment argues that although the Pandemic Fund has adopted a few measures to recognise and address some of the challenges, overall, the Pandemic Fund has unclear policies in response to most of the challenges while leaving many unaddressed.
conclusionIt remains unclear how the Pandemic Fund is explicitly addressing challenges widely recognized in the global health financing literature. Moreover, there is evidence that the Pandemic Fund might be exacerbating these global financing challenges, thus raising questions about its potential efficacy, suitability, and chances of success. In response, this article offers four sets of policy recommendations for how the Pandemic Fund and the PPR financing architecture might respond more effectively to the identified challenges.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.